About Ian Smith
Form D filings for Odyssey Therapeutics in 2024 list Ian Smith as director.
Ian Smith first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ian Smith in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ian Smith works with at each company, as listed on that company's latest Form D.
Odyssey Therapeutics, Inc. · Form D/A, Aug 14, 2024
TW
Timothy Walbert
Director
Charles Baum
Director
GG
Gary Glick
President & CEO, director
JC
Jill Carroll
Director
JL
Jeffrey Leiden
Director
VO
Valerie Odegard
Director
LK
Lorence Kim
Director
CG
Carl Gordon
Director